The Scientist spoke with Rachel Zeig-Owens, the director of epidemiology for the World Trade Center Health Program, about what scientists have learned after two decades of studying illness and disease among survivors.

As COVID-19 therapies get emergency-use green lights, the Biden administration must organize a therapeutic review board to help identify what’s working and what’s not.

Firefighters who didn’t develop obstructive airway disease after the World Trade Center attacks had higher levels of omega-3 fatty acids and other factors that hint at possible protective effects of diet.

The number of measles cases this year is already more than all of the cases reported in 2018.

Some scientists are taking advantage of the monster storm to study how ecosystems and animals respond to major disturbances.

As Hurricane Harvey approaches land, researchers wait to see if their preparations will protect their experiments.

How to increase the resiliency of biotechnology organizations in the face of emergency risks

Along with his recent $250 million donation to cancer research, Silicon Valley entrepreneur Sean Parker emphasized the importance of data sharing.

The United Nations and medical organizations request additional international action on Ebola as the pace of the ongoing epidemic accelerates.

Marijuana use does not correlate with negative health outcomes or hospitalizations, a study has found.

The open-access Public Library of Science has launched a new journal to publish and disseminate scientific information quickly in the wake of disaster.